Injectable Drug Delivery Market by Type (Formulation and Devices), by Application (Autoimmune Diseases, Oncology Disorders, Hormonal Disorders, Orphan Diseases, and Others), and by End-User (Hospital, Home Care, Ambulatory Care, Physician Offices or Clinics, and Others)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020–2029

                                          
Abstract
                    
The report covers a forecast and an analysis of the injectable drug delivery market on a global and regional level. The study provides historical data for 2017 and 2018 along with a forecast from 2019 to 2025 based revenue (USD Billion). The study includes drivers and restraints of the injectable drug delivery market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the injectable drug delivery market on a global level.

In order to give the users of this report a comprehensive view of the injectable drug delivery market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new application launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.

The study provides a decisive view of the injectable drug delivery market based on type, application, end-user, and region. By type, the global injectable drugs market includes formulation and devices. The formulation segment is sub-segmented into conventional drug delivery (suspensions, solutions, lyophilized formulations, and emulsions), novel drug delivery (long-acting injection formulation, colloidal dispersions, and microparticles), and others. The devices segment includes conventional injection devices and self-injection devices. The self-injection devices segment is further classified into needle-free injectors (NFI), pen injectors, wearable injectors, auto-injectors, and others. The conventional injection devices are segmented into prefilled syringes, fillable syringes, and others. By application, the global injectable drug delivery market is segmented into autoimmune diseases, oncology disorders, hormonal disorders, orphan diseases, and others. By end-user, this global market includes home care, hospital, ambulatory care, physician offices or clinics, and others. By geography, the global injectable drug delivery market includes Latin America, North America, Asia Pacific, Europe, and the Middle East and Africa with its further division into major countries, such as the U.S., Rest of North America, UK, Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, Brazil, Rest of Latin America, GCC Countries, South Africa, and Rest of the Middle East and Africa.

Some key players of the global injectable drug delivery market are Baxter International, Nova Nordisk A/S, Becton Dickinson, Sanofi, Pfizer, InjexPharma GmbH, Terumo Corporation, Unilife Corporation, Gerresheimer AG, Vetter Pharma-Fertigung GmbH & Co. KG., Schott AG, and Eli Lily & Company.

This report segments the global injectable drug delivery market into:

Global Injectable Drug Delivery Market: Type Analysis

	Formulation
	
		Conventional Drug Delivery
		
			Suspensions
			Solutions
			Lyophilized Formulations
			Emulsions
		
		
		Novel Drug Delivery
		
			Long Acting Injection Formulation
			Microparticles
			Colloidal Dispersions
		
		
		Others
	
	
	Devices
	
		Self-Injection Devices
		
			Needle-Free Injectors (NFI)
			Wearable Injectors
			Pen Injectors
			Auto-Injectors
			Others 
		
		
		Conventional Injection Devices
		
			Prefilled Syringes
			Fillable Syringes
			Others
		
		
	
	

Global Injectable Drug Delivery Market: Application Analysis

	Autoimmune Diseases
	Oncology Disorders
	Hormonal Disorders
	Orphan Diseases
	Others

Global Injectable Drug Delivery Market: End-User Analysis

	Home Care
	Hospital
	Ambulatory Care
	Physician Offices or Clinics
	Others

Global Injectable Drug Delivery Market: Regional Analysis

	North America
	
		The U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	Middle East and Africa